Logic calculation ECL biosensor based on programmable allosteric DNAzyme and application of logic calculation ECL biosensor
By using a logic-calculated ECL biosensor based on programmable allosteric DNAzyme, combined with dynamic allosteric DNA enzyme and rolling circle amplification technology, the sensitivity of circulating miRNA detection and the complexity of multi-target detection are solved, and AMI, AAD and Early accurate diagnosis of PE.
Patent Information
- Application Number
- CN202411164884.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-12-03
AI Technical Summary
Existing biosensing systems are difficult to achieve sensitivity, efficiency and accuracy in detecting circulating miRNAs, especially due to the complexity of low abundance and multi-target detection, resulting in misdiagnosis or delay in early diagnosis of AMI, AAD and PE.
A logic computing ECL biosensor based on programmable allosteric DNAzyme is designed. Through dynamic allosteric DNA enzyme and rolling circle amplification technology, combined with binary logic gates and multiplexers, it realizes high sensitivity to multiple circulating miRNAs. Detection to reduce the risk of false positive signals and circuit leakage.
It realizes accurate detection of multiple circulating miRNAs, improves detection sensitivity and reliability, and can effectively distinguish cardiovascular diseases such as AMI, AAD and PE in extreme environments, providing a multifunctional diagnostic toolbox.
Smart Images

Figure CN119064429A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of bioanalysis detection, and in particular to a logic calculation ECL biosensor based on programmable allosteric DNAzyme and an application thereof in preparing a detection system for detecting circulating miRNA. Background Art
[0002] Acute myocardial infarction (AMI) is an acute coronary syndrome with a high incidence and misdiagnosis rate. It, along with acute aortic dissection (AAD) and acute pulmonary embolism (PE), are three cardiovascular diseases with chest pain, dyspnea and shortness of breath as the main symptoms. Missed or delayed diagnosis of AMI can lead to high mortality and seriously threaten the life and health of patients. Current diagnostic tests on the circulatory system have demonstrated that there are AMI-related miRNAs in the circulation system, their expression is cell or tissue specific, and the expression pattern can change at the beginning of the pathological process. In addition, these circulating miRNAs are abundant and can exist in the blood in a very stable form, are not affected by endogenous RNase activity, and remain stable even under adverse conditions. These miRNAs in the blood can serve as ideal biomarkers for the early diagnosis, treatment and prognosis of AMI patients, and are increasingly used to assist rapid decision-making in emergency situations, especially for the early and accurate detection and analysis of circulating miRNAs. However, the inherent characteristics of circulating miRNAs, such as low abundance, short length and high sequence similarity between family members, have brought significant difficulties to the sensitive, efficient and accurate detection of miRNAs. It is crucial to develop a versatile and sensitive biosensing platform to simultaneously analyze multiple circulating miRNAs and identify the three related diseases.
[0003] At present, most reported biosensing systems focus on using biomolecular amplifiers to analyze single circulating miRNAs to improve detection sensitivity. However, in actual situations, single-target circulating miRNAs are largely susceptible to interference from false-positive signals, and multiple circulating miRNAs in the circulatory system always co-regulate the functions of AMI-related genes. Single-target detection requires multiple processing to accurately detect multiple AMI-related circulating miRNAs, limiting the demand for practical application of circulating miRNA clinical diagnosis. To address this limitation, the present invention introduces DNA molecular logic gates to construct sensitive biosensors. DNA molecular logic gates are a dynamic DNA nanocomputing device based on DNA self-assembly, with molecular computing as the core element to program variable configurations. Biosensors operated by DNA molecular logic gates are able to perform arithmetic operations and information processing in biological systems by accurately and autonomously analyzing multiple external signals from inputs and generating appropriate output responses in large-scale parallelism. Similar to biomolecular amplifiers for signal amplification, DNA molecular logic gates can also achieve accurate detection of low-abundance multi-cycle miRNAs through signal amplification, and it is easier to adjust and adapt to new applications because both signal amplification and transduction are intrinsically dependent on the programmability of Watson-Crick complementary base pairing. DNAzyme is a catalytic nucleic acid with the advantages of flexible design, easy digestibility, and programmability. It has been proven to be an active ingredient for realizing DNA molecular logic operations and is widely used in various DNA molecular logic gates and biomolecular computing systems. DNAzyme is inspired by the allosteric effect. We try to introduce various DNA brakes to assemble secondary structures around the catalytic domain, resulting in changes in the conformation of the DNAzyme molecule, thereby changing the activity of the DNAzyme. This dynamic programmable variant DNAzyme assembly originates from target-triggered toehold-mediated strand displacement and strand displacement reactions, which can be called dynamic allosteric DNAzyme. The toehold-mediated strand displacement reaction (TMSD) has simple versatility and high biocompatibility, in which the single-stranded overhang region drives the assembly of variant DNAzymes by mediating branch migration through a controllable strand invasion mechanism, thereby reducing the possibility of non-specific background of DNAzymes, the possibility of circuit leakage, and improving reliability. At the same time, by utilizing dynamic variant DNAzyme molecular logic gates in a logic input-output signal-related mode and combining it with other isothermal amplification technologies, multiple amplification of signals will be further achieved to improve the sensitivity of simultaneous input detection of multiple targets and to accurately distinguish AMI from other diseases.The application of DNA molecular logic gates constructed by rationally designed DNAzyme biorecognition elements in the development of multi-target biosensors offers great potential for the integration of gene regulation, target analysis, and molecular diagnosis, and is expected to provide smarter and more accurate decisions for disease diagnosis. Summary of the invention
[0004] The present invention designs and synthesizes a logic computing ECL biosensor based on programmable allosteric DNAzyme and its application. The present invention designs a universal probe for DNA logic computing, which is based on a combination of dynamic allosteric DNA enzymes and rolling circle amplification (RCA) circulating microRNAs. The precise capture of miRNA initiates the signal amplification and transactivation of the dynamic allosteric DNA enzyme, activating the universal DNA enzyme assembly. Subsequently, the product on the universal probe triggers RCA to produce a single-stranded nucleic acid polymer, which contains continuous repeated copies of the complementary sequence, and a strong ECL signal is generated by introducing the single-stranded DNA probe on CdTe-RuSi nanoparticles. A series of binary logic gates including YES, OR, AND and INH gates, as well as more complex 2:1 multiplexers, are constructed. These logic calculations realize the catalytic amplification of DNA enzymes by precisely and spontaneously executing the calculation parameters in the biological system, which greatly avoids the generation of false positive signals, reduces the risk of circuit leakage, and effectively improves the sensitivity of multi-target detection. At the same time, RCA is coupled in the logic system to induce CdTe-RuSi NPs ECL signals, thereby further improving the sensitivity in extreme environments. This method provides a promising toolbox for sensitive detection of low abundance and diversity of multiple circulating miRNAs. The invention can be used to detect, diagnose and treat multi-gene regulated cardiovascular diseases, especially acute myocardial infarction, aortic dissection and acute pulmonary embolism.
[0005] The present invention discloses a logic computing ECL biosensor based on programmable allosteric DNAzyme, which is prepared by the following method: (1) pretreating an electrode; (2) dripping and coating a SnO2 / chitosan / g-C3N4 nanocomposite material on the surface of the pretreating electrode; (3) modifying the surface of the GCE electrode with a substrate hairpin probe; (4) adding MCH (thiol polyethylene glycol SH-PEG) to prevent nonspecific binding; and (5) adding a cyclic amplification unit constructed by assembled different logic computing gates (YES gate, OR gate, AND gate, INHIBIT gate and 2:1MUX gate), wherein the cyclic amplification unit and the substrate hairpin probe form a programmable allosteric DNA enzyme structure. The allosteric DNA enzyme cuts the substrate hairpin probe to generate a large number of trigger chains for the subsequent rolling circle amplification (RCA) reaction; (6) the padlock probe, DNA ligase, 10×T4 buffer, PEG4000, EXOⅢ and 10mM Mg2+ are co-dropped on the electrode surface to directly cyclize and produce circular DNA (circular DNA required for the RCA reaction); (7) dNTPs, 1μL Pi29 polymerase, Pi29 buffer and 10 mM Mg2+ are added to the electrode surface, and the circular DNA continues to expand along the trigger chain to eventually generate an RCA product with continuous repeated copies; (8) the CdTe-RuSi NP-CONH-DNA probe is added to the electrode surface for incubation, and the CdTe-RuSi NP-CONH-DNA probe is introduced to the electrode surface by hybridization with the RCA product.
[0006] As a preferred embodiment, in the above-mentioned ECL biosensor, the pretreatment in step (1) includes polishing, cleaning and drying.
[0007] As a preferred embodiment, in the above-mentioned ECL biosensor, step (2) of dripping and coating on the electrode surface refers to dripping the SnO2 / chitosan / g-C3N4 nanocomposite as a substrate for subsequent reactions, and drying naturally after dripping, so that a thin layer of the SnO2 / chitosan / g-C3N4 nanocomposite is formed on the electrode surface. The preparation of the SnO2 / chitosan / g-C3N4 nanocomposite can refer to the literature Liu, XP; Huang, B.; Mao, CJ; Chen, JS; Jin, BK, Electrochemiluminescence aptasensor for lincomycin antigen detection by usinga SnO2 / chitosan / g-C3N4 nanocomposite. Talanta. 2021, 233 , 122546.
[0008] As a preferred embodiment, in the above-mentioned ECL biosensor, step (3) modification on the electrode surface refers to connecting the substrate hairpin probe to the electrode surface. The substrate hairpin probe can be designed to have a thiol group (-SH), and SnO2 is present on the electrode after the treatment in step (2), so that the substrate hairpin probe can be modified and connected to the electrode surface through the Sn-S bond. The substrate hairpin probe includes Si-HP (rA) and Si-HP1 (rA), and their sequences are SEQ ID NO. 1 and SEQ ID NO. 2 in the sequence table, respectively, as follows: Si-HP(rA): 5'- CTGATAAGCTACAGGACATCGAACAGTCTTTTGAGCGACACACTAT rAGGAAGAGATACTTTTGACTGTTCGA-3'.
[0009] The underlined sequence above is the sequence of trigger chain trigger-1.
[0010] Si-HP1(rA): 5'- CTGATAAGCTACAGGACATCGAACAGTCTTTTACTGCAAGTCTTAT rAGGAAGGGCAGATTTTGACTGTTCGA-3'.
[0011] The underlined sequence above is the sequence of trigger chain trigger-2.
[0012] Among them, modified Si-HP(rA) can be used for programmable conformational changes of YES gate and OR gate, and subsequently the trigger chain trigger-1 is obtained and then used for rolling circle amplification; modified Si-HP1(rA) can be used for programmable conformational changes of AND gate, INHIBIT gate and 2:1MUX gate, and subsequently the trigger chain trigger-2 is obtained and then used for rolling circle amplification.
[0013] As a preferred embodiment, in the above-mentioned ECL biosensor, in step (4), MCH is modified to prevent non-specific binding to the electrode surface.
[0014] As a preferred embodiment, in the above-mentioned ECL biosensor, in step (5), a complete programmable allosteric DNA enzyme structure for cutting reaction can be formed by incubating the cyclic amplification unit with the substrate hairpin probe at 37°C. Wherein, the sequences of the auxiliary A chain (A-YES, A-OR, A-AND, A-INH, A-MUX, PA), auxiliary B chain (B-YES, B-OR, B-AND, B-INH, B-MUX, PB), target (miRNA-499, 328, 15a, 1233), and brake B (B1, B2, B3, B4, B5) required for different logic calculations are SEQ NO3-SEQ NO23 in the sequence table. The present invention can integrate these five logic gates (YES gate, OR gate, AND gate, INHIBIT gate and 2:1MUX gate), and there will be ECL response for multiple targets, so it can be used for simultaneous detection of multiple targets.
[0015] Among them, the assembly method of the cyclic amplification unit constructed by the YES gate is to mix 1.0μM auxiliary A chain (A-YES), the corresponding target miRNA (miRNA-499) and 1μM DNA brake B2 locked auxiliary B chain (B-YES / B2); B-YES / B2 is formed by annealing DNA brake B2 with auxiliary B chain (B-YES) at 90°C. Subsequently, the cyclic amplification unit is incubated with the substrate hairpin probe at 37°C for 3h to form a complete programmable allosteric DNA enzyme structure for cutting reaction.
[0016] The OR gate constructed cyclic amplification unit was obtained by mixing 1.0 μM auxiliary A chain A-OR, the corresponding target miRNA (miRNA-328, miRNA-499), and 1.0 μM auxiliary B chain B-OR / B1 / B2 locked by DNA brakes B1 and B2; wherein B-OR / B1 / B2 was formed by annealing DNA brakes B1 and B2 together with auxiliary B chain B-OR; The cyclic amplification unit constructed by AND gate is obtained by mixing the auxiliary A chain A-AND / B3 / B4 locked by 1.0μM DNA brakes B3 and B4, the corresponding target miRNA (miRNA-328, miRNA-499), and 1.0μM auxiliary B chain B-AND; wherein A-AND / B3 / B4 is formed by annealing DNA brakes B3 and B4 together with auxiliary A chain A-AND; The cyclic amplification unit constructed by the INHIBIT gate is obtained by mixing the auxiliary A chain A-INH / B4 locked by 1.0μM brake B4, 1.0μM auxiliary B chain (B-INH), and target miRNA (miRNA-499, miRNA-15a); wherein A-INH / B4 is formed by annealing the DNA brake B4 with the auxiliary A chain A-INH; The cyclic amplification unit constructed with 2:1MUX gate was obtained by mixing 1.0μM auxiliary B chain (B-MUX), 1.0μM auxiliary A chain locked by brake B5 A-MUX / B5, auxiliary PB chain locked by brake B3 (PB / B3), auxiliary PA chain (PA) and target miRNA (miRNA-499, miRNA-15a, miRNA-1233); A-MUX / B5 was formed by annealing brake B5 with auxiliary A chain, and PB / B3 was formed by annealing brake B3 with auxiliary PB chain; The sequences of the auxiliary A chain (A-YES, A-OR, A-AND, A-INH, A-MUX, PA), auxiliary B chain (B-YES, B-OR, B-AND, B-INH, B-MUX, PB), target (miRNA-499, 328, 15a, 1233), and brake B (B1, B2, B3, B4, B5) required in step (5) are SEQ NO3 to SEQ NO23 in the sequence list as follows: A-YES: 5'- AAACATCACTGCAAGGACCCATGTTAGTGTGTCGCTC -3'; A-OR: 5'- GGGCAGAGAGGGCCAGAAACATCACTGCAAGGACCCATGTTAGTGTGTCGCTC -3'; A-AND: 5'- TGATTTGTAGTGACGTTCGACCCATGTTAAGACTTGCAGT -3'; A-INH: 5'-CATAATGGTTTGTGGACCCATGTTAAGACTTGCAGT -3'; A-MUX: 5'- TGCAGTGATGTTTGACCCATGTTAAGACTTGCAGT -3'; PA: 5'-TGCCGTGCCCTGTTAGACCCATGTTAAGACTTGCAGT -3'; B-YES: 5'- GTATCTCTTCCGCGATCTTGCAGTGATGTTT-3'; B-OR: 5'-GTATCTCTTCCGCGATCTTGCAGTGATGTTTCTGGCCCTCTCTGCCC-3'; B-AND: 5'-TCTGCCCTTCCGCGATGAACGTCACTACAAATCA-3'; B-INH: 5'-TCTGCCCTTCCGCGATCACAAACCATTATGTGCTGCTA-3'; B-MUX: 5'-TCTGCCCTTCCCGCATAAACATCACTGCAAGTCTTAACTGGCCCTCTCTGCCCTT C-3'; PB: 5'-TCTGCCCTTCCCGCGATTAACGGCCTCCCACT-3'; miRNA-499: 5'-TTAAGACTTGCAGTGATGTTT-3'; miRNA-328: 5'-CTGGCCCTCTCTGCCCTTCCGT-3'; miRNA-15a: 5'-TAGCAGCACATAATGGTTTGTG-3'; miRNA-1233: 5'-AGTGGGAGGCCAGGGCACGGCA-3'; B1: 5'-ACGGAAGGGCAGAGAGGGCCAG-3'; B2: 5'-AAACATCACTGCAAGTCTTAA-3'; B3: 5'-GAAGGGCAGAGAGGGCCAG-3'; B4: 5'-AAACATCACTGCAAGTCTTA-3'; B5: 5'-AAACATCACTGCAAGTCTTA-3'; As a preferred embodiment, in the above-mentioned ECL biosensor, in step (6), a padlock probe, T4 DNA ligase, EXOⅢ and buffer are added and incubated at 37°C for 30 minutes to directly cyclize and generate circular DNA. EXOⅢ cuts the unligated padlock probe. The padlock probe sequence is SEQ ID NO.24, as follows: AGTAAAAGACTAACGTAGTTCACGTATAGAAATAAGACTTGC; As a preferred embodiment, in the above-mentioned ECL biosensor, in step (7), dNTP, Pi29 polymerase and Mg2+ are added and incubated at 37°C in the dark for 2 hours to cause rolling circle amplification (RCA) to generate RCA products with continuous repeat copies.
[0017] As a preferred embodiment, in the above-mentioned ECL biosensor, in step (8), CdTe-RuSi NP-CONH-DNA probe is added to the electrode surface and incubated in a dark environment for 4 hours.
[0018] As a preferred embodiment, the above-mentioned ECL biosensor can be prepared by the following method: (1) Polish the electrode with alumina slurry, rinse thoroughly with ultrapure water, ultrasonically treat in ethanol and water, and dry at room temperature; (2) Add 10 μL SnO2 / chitosan / g-C3N4 solution to the electrode surface to form a thin layer on the GCE electrode surface; (3) Add 10 μL of 3 μM substrate probe with rA site on the electrode and incubate for 4 h to 6 h; (4) Add 1 mM MCH and incubate for half an hour to prevent nonspecific adsorption; (5) adding different auxiliary chains, targets and brakes to assemble a series of different cyclic amplification units, which together with the substrate hairpin probe form a complete allosteric DNAzyme; (6) Allosteric DNAzyme cleaves the substrate hairpin probe to generate a trigger strand, and 1 μM 1 μL padlock probe, 0.05 U / μL 1 μL T4 DNA ligase, 10× T4 buffer, PEG4000, EXOⅢ, and 10 mM 10 μL Mg2+ are co-dropped onto the electrode surface and incubated at 37°C for 30 min to directly cyclize and generate circular DNA (circular DNA required for RCA reaction); (7) 0.2 U / μL of 1 μL dNTP, 0.5 U / μL of 1 μL Pi29 polymerase, Pi29 buffer and 10 mM Mg2+ were added. The circular DNA was continuously extended along the trigger chain to eventually generate an RCA product with continuous repeat copies.
[0019] (8) 1 μM 10 μL CdTe-RuSi NP-CONH-DNA probe was added to the electrode surface and incubated in the dark for 4 h. At this time, the CdTe-RuSi NP-CONH-DNA probe formed a double-stranded structure with the RCA product with continuous repeat copies through hybridization. The CdTe-RuSi NP-CONH-DNA probe was introduced to the electrode surface for ECL measurement. The ECL photomultiplier tube was 800 V, and the scanning rate was 0.1 / s from 0 to 1.2.
[0020] In step (8), the probe here refers to DNA with an OH functional group, which can be purchased from a professional custom manufacturer such as Sangon Biotech (Shanghai) Co., Ltd. The CdTe-RuSi NP-CONH-DNA probe sequence is SEQ ID NO. 25, which is as follows: Probe sequence: 5'-COOH-TTTTTTTTTTCGTATGTTCACGTATAG-3' The surface of CdTe-RuSi NP material itself has NH 2 Functional groups (CdTe-RuSi NP-NH 2 ), at this time, it is necessary to activate the NH 2 Then the DNA with COOH functional groups and the activated CdTe-RuSi NP-NH 2 Shock, NH 2 The functional group and COOH functional group form an amide bond (CONH), so DNA can be modified on the surface of CdTe-RuSi NP to form CdTe-RuSi NP-CONH-DNA. (The surface of CdTe-RuSi NP material itself has NH 2 From SiO 2 Shell, SiO 2 Encapsulate CdTe quantum dots and Ru molecules). RuSi NP material connects DNA (SiO 2 Encapsulation and Ru molecules) can be referenced in: Sun, Y.; Fang; Han, Y.; Feng, A.; Liu, S.; Zhang, K; Xu, JJ, Reversible Ratiometric Electrochemiluminescence Biosensor Based on DNAzyme Regulated Resonance EnergyTransfer for Myocardial miRNA Detection. Anal. Chem. 2022, 94 (19), 7035-7040.
[0021] The present invention has established a series of ECL biosensors based on binary logic gate coupled cascade amplification for specific detection of circulating miRNAs related to cardiovascular diseases such as acute myocardial infarction, aortic dissection and acute pulmonary embolism. The present invention relates to a logic calculation ECL biosensor based on programmable allosteric DNAzyme and its application in the preparation of a detection system for detecting circulating miRNAs and the identification of three diseases: acute myocardial infarction, aortic dissection and acute pulmonary embolism.
[0022] The mechanism of molecular logic gate or logic calculation ECL sensing based on allosteric DNAzyme to identify AMI and other nonspecific diseases is analyzed as follows: 1. Mechanistic detection of circulating miRNAs based on the ECL sensing of the “YES” logic gate of allosteric DNAzyme.
[0023] To simplify complex logic language, low signals (0) and high signals (1) in all Boolean logic gates are used to represent the input or output of signals. The YES gate is the simplest logic gate with the same output and input, and can be used as a component of more complex logic operations. In recent years, the use of analog circuit theory in physics has enabled a deep understanding of the language of abstract molecular logic gates or logic circuits in biology. Using the "YES" logic gate, accurate detection of circulating miRNA-499 can be achieved. A substrate probe (Si-HP(rA)) with RNA splicing sites was modified on the GCE coated with SnO2 / chitosan / g-C3N4 nanocomposite. Next, MCH was added to the space on the electrode to block nonspecific sites. In the "YES" logic gate based on allosteric DNAzyme, miRNA-499, a biomarker of acute myocardial infarction, was used as the signal input of the "YES" logic gate, that is, circulating miRNA-499 was mixed with programmable auxiliary chains (auxiliary A-YES, auxiliary B-YES) and DNA brake B2 and added to the electrode surface. Among them, the target triggers the strand displacement reaction of the DNA brake, and the auxiliary B-YES and auxiliary A-YES form a complete ring structure B-YES / A-YES, which is assembled on the substrate probe to form an allosteric DNAzyme to produce a trigger product (trigger chain trigger). Next, the trigger product triggers RCA amplification, and through a single-stranded nucleic acid polymer with continuous repeat copies. A large number of ssDNA probes on CdTe-RuSi nanoparticles (CdTe-RoSi NPs) are anchored to the electrode surface by hybridizing with single-stranded nucleic acid polymers, generating a strong ECL signal. The assembly of this easily adjustable and universal allosteric DNAzyme greatly improves the sensitivity of the multi-level signal amplification of circulating miRNA, reduces the possibility of nonspecific background signals and circuit leakage, and effectively improves the detection reliability.
[0024] 2. Detection of multiple AMI-related circulating miRNAs using binary logic gate ECL sensing based on allosteric DNAzyme.
[0025] (1) “OR” Boolean logic gate The OR gate is a basic Boolean logic gate, and the logical operation can realize multiple parallel reactions and produce the same output results at the same time. The OR Boolean logic gate has various input combinations (0,0; 0,1; 1,0; 1,1), in which no output (0) is produced without any input (0,0); once any input (0,1; 1,0; 1,1) is available, the corresponding output (1) is produced. Therefore, the OR Boolean logic gate can detect any combination of inputs and calculate the logical sum of the input variables, that is, perform a union operation. Based on the highly biocompatible, simple and universal entropy-driven chain substitution principle, an OR Boolean logic gate biosensing platform was designed for entropy-driven allosteric DNAzyme to amplify the signal and accurately detect AMI-related circulating miRNAs (miRNA-499, miRNA-328) at the same time. The sensing module of the dual-input OR Boolean logic gate consists of two parts, including auxiliary B (B-OR) (B1, B2) protected by DNA brakes and auxiliary A (A-OR), in which the structural arm of B-OR forms a double-stranded complex with B1 and B2 (B-OR / B1 / B2). Importantly, entropy-driven DNA chain substitution is used to control the hybridization state of the BOR structural arm, and B-OR / B1 / B2 and A-OR can stably coexist in solution. Without the input of any DNA chain (input 0,0), the structural arm of B-OR in the processing module is protected by B1 and B2, which prevents the reaction with A-OR to produce a complete allosteric DNAzyme. Therefore, there is no signal output. When the target miRNA-328 is input (input 0,1), the miRNA-32 in the processing module can first hybridize with B1 in B-OR / B1 / B2 through a 6-nt toehold to form a complex structure of B-OR / B2 and B1 / miRNA-328. Next, a 16nt single-stranded domain is exposed in B-OR / B2, which promotes the upstream strand displacement reaction with a-OR, ultimately forming a complete entropy-driven allosteric DNA enzyme structure and outputting an ECL signal (output 1). Similarly, when the target miRNA-499 is input (input 1,0), the downstream strand displacement of B-OR / B1 is promoted, generating a strong ECL signal (output 1). When the target miRNA-328 and miRNA-499 are input simultaneously (1,1), the two reactions in the processing module perform tandem operations in parallel to generate a signal (1).
[0026] (2) “AND” Boolean logic gate Similar to the "OR" gate, the "AND" gate is also a basic Boolean logic gate whose logic operation performs a cascade operation of multiple continuous processes to produce the same output result. The dual-input AND Boolean logic gate is an AND logic gate with two reactants as inputs. In the dual-input AND Boolean logic gate operation, only two inputs exist at the same time (input 1, 1) to perform the cascade operation and produce the same output (output 1); on the contrary (input 0, 0; 01; 10), the continuous cascade operation cannot be completed and there is no output (output 0). Therefore, the dual-input AND Boolean logic gate can detect whether the two inputs exist at the same time and calculate the logical product of the input variables. That is, a crossover operation is performed. It is reported that multiple miRNAs always co-regulate AMI genes. Single target detection cannot meet practical needs. In this patent, a dual-input AND Boolean logic gate is designed for accurate detection of AMI-related circulating miRNAs (miRNA-328, miRNA-499). Auxiliary B (B-AND) and auxiliary A (A-AND) are assembled to form a circular amplification unit structure (B-AND / A-AND), and DNA brakes B3 and B4 control the recognition domain after B-AND / AND to form a B3 / B-AND / A-AND / B4 complex, which constitutes a sensing module with a dual-input AND Boolean logic gate. Entropy-driven DNA strand displacement is used to control the hybridization state of B-AND / A-AND. In the absence of any DNA strand input (0, 0), B3 / B-AND / AND / B4 in the processing module cannot form a complete allosteric DNA enzyme structure with the substrate probe. Therefore, there is no signal output (output 0). When the target miRNA-328 is input (input 0, 1), miRNA-32 in the processing module can first hybridize with B3 of B3 / BAND / A-ND / B4 through a 7-nt foothold to form a complex structure of B-AND / A-AND / B4. The complex structure of B-AND / A-AND / B4 cannot form a complete allosteric DNAzyme structure due to the inhibitory effect of B4, and cannot output a signal (output 0). According to the same principle, inputting the target miRNA-499 (input 1,0) also cannot output a signal (output 0). Only by simultaneously inputting the target miRNA-328 and miRNA-499 (input 1,1), the input miRNA-328 and miRNA-499 react with B3 and B4 in B3 / B-and / and / B4 respectively through entropy-driven strand displacement, resulting in the dissociation of B3 and B4 from B3 / B-AND / A-AND / B4, and finally activating B-AND / A-AND to form a complete allosteric DNAzym structure with the substrate probe, generating a signal output (output 1).
[0027] (3) “INHIBIT” Boolean logic gate Acute aortic dissection (AAD) is a serious cardiovascular disease with a high mortality rate. AMI patients also often present with symptoms similar to the clinical manifestations of AAD, making AMI one of the most common differential diagnoses of AAD. It has been reported that circulating miRNA-15a can serve as a specific biomarker for AAD. Therefore, the precise detection of circulating miRNA-15a and circulating miRNA-499 in a complex blood environment provides a useful and reliable tool for the diagnosis of AAD and AMI, respectively. In order to accurately identify the type of cardiovascular disease with nonspecific clinical manifestations, more and more studies have focused on the fabrication of INHIBIT Boolean logic gates to achieve multifunctional information processing of circulating miRNAs. Here, we designed an INHIBIT Boolean logic gate with circulating miRNA-499 and miRNA-15a as signal inputs for accurate identification of AMI and AAD. When the input signal is miRNA-499 (input 1,0), a strong signal (output 1) is generated. However, regardless of the presence of miRNA-499, as long as miRNA-15a acts as an inhibitory element and participates in the reaction (input 0,1; 1,1), there is no corresponding signal output (output 0). Specifically, auxiliary B (B-INH) and auxiliary A (A-INH) are assembled to form a circular amplification unit structure (B-INH / A-INH. Target miRNA-15a is input into the INHIBIT 9 Boolean logic gate (input 0, 1), and target miRNA15a can hybridize with the B-INH / A-INH / B4 complex through the 8-nt foothold, resulting in the dissociation of the complex A-INH / B4- without forming an allosteric DNA enzyme and no signal output (output 0). Similar to the AND Boolean logic gate principle, when target miRNA-499 is input (input 1,0), miRNA-49 hybridizes with B4 through the 7-nt foothold, resulting in a B4 / miRNA-499 double-stranded structure and a B-INH / a-INH complex. Finally, the B-INH / A-INH complex structure forms an allosteric DNAzyme for signal output with the substrate probe (output 1). When the target miRNA-15a and target miRNA-499 are simultaneously input (input 1, 1), the toeholds of B-INH and B4 in the B-INH / A-INH / B4 complex structure hybridize with miRNA-15a and miRNA-499 to form double-stranded structures B-INH / miRNA-15 and B4 / miRNA-499 without corresponding signal output (output 0).
[0028] (4) “2:1MUX” Boolean logic gate (2:1 multiplexer) Similar to AMI and AAD, acute pulmonary embolism (PE) has chest pain as the main clinical symptom and has a high mortality rate worldwide. Therefore, it is crucial to distinguish and accurately detect acute myocardial infarction from AAD and PE. DNA, as a versatile building block, cannot simultaneously analyze multiple disease biomarkers through basic DNA molecular logic gates for binary computing, endowing chest pain as the main symptom feature for disease identification. The development of biosensing systems based on advanced DNA molecular logic gates for simultaneous analysis and identification of multiple diseases is imminent. Multiplexers that perform non-arithmetic operations are an advanced DNA molecular logic gate that has been widely used for the requirements of protein, ion and nucleic acid logic analysis. Here, we used circulating miRNA-499 / miRNA-328 (gold standard for AMI), miRNA-15a (gold standard for AAD) and miRNA-1233 (gold standard for PE detection) as signal inputs to establish a 2:1 multiplexer that performs non-arithmetic operations to achieve simultaneous identification and detection of AMI, AAD and PE. The sensing module is composed of the recognition domain of B5 controlling the structure of the B / A complex to form the B5 / B / A complex and the recognition domain of B3 controlling the PB / PA complex to form the B3 / PB / PA complex, in which miRNA-499 acts as a switch of the logic system to control the entire logic reaction. When there is no target miRNA499, the entire upstream system is in the signal "off" state. In the "OFF" state, only miRNA-15a exists (input 0, 1, 0), and miRNA-15a can hybridize with B5 through the toe in the processing module (the sequence extended from the processing module DNA chain without complementary pairing) to form a B / a complex structure and generate signal output (output 1); in the presence of miRNA-1233 (input 0, 0, 1), miRNA-1233 immediately assembles with the B3 / PB / PA complex to form a more stable miRNA-1233 / B3 / PB / PA-structure without signal output (output 0); the simultaneous input of target miRNA-15a and miRNA-1233 (input 0, 1, 1) forms a B / A complex structure to generate an output signal (output 1).
[0029] The processing module in the "off" state acts as a sensing module for the downstream system. In the presence of target miRNA-499, the downstream logic system is in the signal "ON" state. In the processing module in the "ON" state, a single input miRNA-499 (input 1, 0, 0) can first hybridize with the B / A / B5 complex through the toe, promoting the dissociation of the double-stranded structure including B / miRNA-49 and A / B4 from B / A / B4, and there is no signal output (output 0); in the sensing module composed of the B / A complex structure and the B3 / PB / PA complex structure, due to the presence of dual input miRNA-499 and miRNA15a (input 1, 1, 0), a B / miRNA-499% complex with a "sticky end" is generated, which promotes the dissociation of B3 from the B3 / PB / PA-complex structure and finally forms a B / miRNA-469 / B3 complex (output 0); based on the same principle, by inputting target miRNA-499 and target miRNA-1233 into the sensing module composed of B / a / B5 and miRNA-1233 / B3 / PB / PA complex structures, a miRNA-1233 / B3 / PB / PA complex is formed. 33 / PB / PA complex (output 1); the sensing module composed of B / A and miRNA1233 / B3 / PB / PA complex structure simultaneously inputs miRNA-499, miRNA-15a and miRNA-1233 (1, 1, 1), and finally forms B / miRNA-499 / B3 and miRNA.1233 / PB / PA structures in the downstream processing system to generate signal output (output 1).
[0030] In this paper, a series of ECL biosensors based on binary logic gate-coupled cascade amplification were established using programmable allosteric DNAzymes as biosensitive elements and AMI biomarkers (circulating miRNA-329, circulating miRNA-499) as inputs for specific detection of circulating miRNAs associated with AMI. The ECL biosensor coupled to cascade amplification by the simplest "YES" gate can sensitively detect circulating miRNA-499 with a detection limit as low as 62aM (S / N=3). Differentiation between acute myocardial infarction (AMI), acute aortic dissection (AAD), and pulmonary embolism (PE) may be challenging due to similar clinical manifestations. On this basis, we used multiple biomarkers associated with related diseases as signal inputs to construct ECL biosensors based on more complex logic computation circuits to further achieve the detection and differentiation of AMI from AAD and PE. The biocomputational circuit constructed by regulating the intrinsic versatility and sensitivity of variant DNAzymes helps to solve the diversity and low abundance of circulating miRNAs and provides a promising toolbox for high-sensitivity detection of circulating miRNAs and diagnosis and treatment of multi-gene-regulated cardiovascular diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 Schematic diagram of the mechanism of “YES” logic gate ECL sensing to detect circulating miRNA; Figure 2 The feasibility of the "YES" logic gate and RCA reaction design was verified by gel electrophoresis experiments; Figure 3 The feasibility of the "OR" logic gate design was verified through gel electrophoresis experiments; Figure 4 The feasibility of the "AND" logic gate design was verified through gel electrophoresis experiments; Figure 5 The feasibility of the "INH" logic gate design was verified through gel electrophoresis experiments; Figure 6 The feasibility of the 2:1 multiplexer design was verified by gel electrophoresis experiments. DETAILED DESCRIPTION
[0032] Using the mirbase database, circulating related miRNAs (miRNA-328, miRNA-499, miRNA-15a, miRNA-1233) were screened as analysis objects and provided by Suzhou Jima Gene Co., Ltd.
[0033] Example 1 Schematic diagram of the mechanism of “YES” logic gate ECL sensing to detect circulating miRNA SnO2 / chitosan / g-C3N4 nanocomposite (10 μL) was drop-coated on a well-polished GCE surface and allowed to dry naturally. Then, 10 μL of 0.1 M PBS buffer (pH = 7.4) containing 3 μM substrate hairpin probe, substrate hairpin probe Si-HP (rA) was dropped onto the electrode and incubated at 37 °C for 4 h. Next, 1 mM MCH was introduced to prevent nonspecific adsorption. For the assembly of programmable allosteric DNA enzymes, 1.0 μM auxiliary A chain (A-YES), 1.0 μM miRNA-499, and 1 μM auxiliary B chain locked by DNA brake B2 (B-YES / B2) were mixed and incubated with substrate probe at 37 °C for 3 h to form a complete programmable allosteric DNA enzyme structure for cleavage reaction. Substrate hairpin probe Si-HP (rA) was cleaved to generate a large amount of trigger chain for subsequent rolling circle amplification reaction. Rinse the electrode with 0.1M PBS buffer (10mM Mg2+). Rinse can remove unmodified Si-HP(rA) and excess 0.1M PBS buffer and allosteric DNA enzyme on the electrode surface. Allosteric DNA enzyme completes its mission by cleaving Si-HP(rA) to generate trigger chain, so rinsing can remove excess allosteric DNA enzyme on the electrode surface to protect subsequent reactions from being affected. Subsequently, 1μM, 1μL padlock probe, 0.05U / μL 1μL T4 DNA ligase, 10×T4 buffer, PEG4000, EXOⅢ and 10mM 10 μLM Mg2+ were co-dropped into the DNAzyme product system and incubated at 37°C for 30min to produce circular DNA (circular DNA required for RCA reaction); 0.2 U / μL 1μL dNTP, 0.5 U / μL 1μL Pi29 polymerase, Pi29 buffer and 10 mM Mg2+ were added, and the circular DNA continued to extend along the trigger chain to finally generate RCA products with continuous repeat copies. Finally, 1μM 10μL CdTe-RuSi NP-CONH-DNA was dropped onto the electrode containing the RCA product and incubated in a dark environment for 4h. At this time, the CdTe-RuSi NP-CONH-DNA probe formed a double-stranded structure by hybridization with the RCA product with continuous repeat copies, and the CdTe-RuSi NP-CONH-DNA probe was introduced to the electrode surface. ECL characterization was performed in 0.1 M PBS buffer (pH 7.4) containing 15 mM TPA and 0.1 M KCl.
[0034] like Figure 2 Shown is the use of polyacrylamide gel electrophoresis (PAGE) to analyze DNA structures alone.
[0035] Figure 2In A: 10% PAGE analysis of allosteric DNAzyme. Lane (1) A-YES , (2) B-YES+B2, (3) B-YES+A-YES, (4) HP(rA), (5) HP, (6)trigger-1, (7) miRNA-499, (8) B2+miRNA-499, (9)B-YES+B2 +A-YES+miRNA-499, (10) B-YES+B2+A-YES+ HP(rA)+miRNA-499, (11) B-YES+B2 +A-YES+ HP+miRNA-499. Figure 2 6% PAGE of the allosteric RCA products in B (Lanes 1-8: trigger, Padlock Problem, T4 DNA ligase, trigger+Padlock Problem+T4 DNA ligase+EXO3(EXOⅢ), trigger+ Padlock Problem+ T4 DNA ligase+EXO3+Pih29 DNA polymerase, trigger+ Padlock Problem+ T4 DNA ligase+EXO3+Pih29 DNA polymerase +dNTP; HP(rA)is the substrate hairpin probe Si-HP(rA), HP is the substrate hairpin probe without rA site, trigger-1 is the DNA sequence formed by the allosteric DNAzyme cleaving the substrate hairpin probe Si-HP(rA).
[0036] like Figure 2 As shown in A, in lane 9, a clear new band was observed in the mixture of B-YES chain, B2 chain and A-YES chain after adding the target (lane 3 and lane 8), indicating the formation of a circular amplification unit. When all nucleic acids were present, a new band appeared, indicating the successful assembly of the complete allosteric DNA enzyme (lane 10). Comparing lanes 10 and 11, the probe with the rA site formed a complete allosteric DNA enzyme with the circular amplification unit and the subsequent cleavage probe, generating a new band with the same position as the expected product chain, confirming the smooth cleavage of the allosteric DNAzyme.
[0037] like Figure 2As shown in B, a clear band appears in lane 1, which is the cleavage product of the allosteric DNA enzyme. When both the cleavage product and T4 DNA ligase are present, a new ladder band appears, indicating that a complex constructed by the cleavage product and the circular template is formed (lane 3). In the presence of Exo III, the ladder band disappears, and a very light band appears, indicating that the digestion of the cleavage product proceeds smoothly and a circular template is formed (lane 4). When all components participate in the reaction, the RCA product shows clear band characteristics, indicating that the cleavage product of the variant DNAzyme successfully triggers the RCA reaction.
[0038] like Figure 3 The figure shows that the feasibility of the "OR" logic gate design scheme is verified through gel electrophoresis experiments.
[0039] As shown in the figure, in lane 2, a new band appeared in the mixture of B-OR, B1 and B2, indicating the formation of a double-stranded complex (B-OR / B1 / B2). The presence of target miRNA-328 showed a clear band, proving the formation structure of the circular amplification unit (lane 9). When all nucleic acids were present, comparing lanes 10 and 11, only the circular amplification unit formed an allosteric DNAzyme structure with the rA site, generating a new band at the same position as the expected product chain, confirming the smooth cleavage of the allosteric DNA enzyme. Similarly, targeting miRNA-499 for signal input produced the same results.
[0040] Figure 4 The feasibility of the "AND" logic gate design was verified through gel electrophoresis experiments; As shown in the figure, in lane 3, a new band appeared in the mixture of DNA brakes (B3, B4) and circular amplification units (B-AND / A-AND), indicating that the B-AND / A-AND structure could not be formed due to the blockage of B3 and B4. A single input target miRNA could not form a complete combined structure, so no new band was generated at the expected product chain position (channel 9 vs channel 12). Target miRNA-328 and target miRNA-499 existed at the same time, forming a complete allosteric DNAzyme structure (channel 6 and channel 17) and cutting the hairpin probe with rA site to generate the same band as the expected product (channel 9 vs channel 16), proving the smooth digestion of DNAzyme.
[0041] Figure 5 The feasibility of the "INH" logic gate design was verified through gel electrophoresis experiments; As shown in the figure, in lane 3, a new band appeared in the mixture of B-INH, A-INH and B4, indicating the formation of a locked complex structure (B-INH / A-INH / B4). When the target miRNA-499 was present, comparing lanes 9 and 10, the combined structure formed an allosteric DNAzyme with an rA site, producing a new band in exactly the same position as the expected 10 product chain, proving that the allosteric DNA protease digestion proceeded smoothly. In lanes 12 and 14, two new bands appeared, respectively, indicating that B-INH / miRNA-15a and A-INH / B4 formed a double-stranded structure. When the target miRNA-15a was present in lane 13, a thickened band appeared in the mixture of B-INH, a-INH and B4, which was exactly located in the same position as the double-stranded structure of B-INH / miRNA-15a and A-INH / B4, indicating that the entropy-driven strand displacement reaction proceeded smoothly. The presence of both target miRNA-499 and target miRNA-15a in lane 15, and the appearance of a new band at the expected B4 / miRNA-499 double-stranded structure position, indicated that the reaction was successful. Trigger-2 is a DNA sequence formed by the cleavage of the substrate hairpin probe Si-HP1 (rA) by the allosteric DNAzyme.
[0042] Figure 6 The feasibility of the 2:1 multiplexer design was verified by gel electrophoresis experiments.
[0043] like Figure 6 As shown in A, in the upstream system in the signal "off" state, a new band appeared in the mixture of target miRNA-15a, B5 / B / A, proving that the chain displacement occurred smoothly to produce the duplex structure of miRNA-15a / B (channel 7 vs. channel 8). At the same time, using target miRNA-15a, a complete allosteric DNAzyme was formed (channel 8 vs. channel 9), and the hairpin probe with rA site was cut (lane 9 vs. lane 10), and a new band with the same position as the expected product chain was produced (channel 6 and channel 9). Using target miRNA-1233, due to the presence of blocking chain B3 (channel 12 vs. channel 13), the hairpin probe with rA site (channel 14) could not be cut and the corresponding new band could not be produced (channel 6 vs. channel 14). These structures successfully proved the successful construction of the upstream logic system in the signal "off" state. In the presence of target miRNA-499, the downstream logic system is in the signal "ON" state, and the corresponding gel electrophoresis diagram is as follows Figure 6As shown in B, a new band appeared in channel 8, which was located at the same position as channel 7, proving the formation of miRNA-499 / B and A / B5 duplex structures. Using target miRNA-499 and miRNA-15a, a new band appeared in the mixed solution of B, PB, PA, and B3, proving the formation of miRNA-499 / B3 / B hybrid structure (channel 6 and channel 11). When miRNA-1233 was present, a new band appeared in the mixture of PB and PA (channel 4 vs. channel 15), and the hairpin probe with rA site was cut (channel 15 vs. channel 17), resulting in new bands at the same position as the expected product chain (channel 14 and channel 16). These structures successfully demonstrated the successful construction of the downstream logic system of the signal "on" state.
[0044] It should be noted that the above-mentioned technical contents of the present invention are only for explanation and clarification to enable those skilled in the art to understand the technical essence of the present invention, so the technical contents are not used to limit the substantial protection scope of the present invention. The substantial protection scope of the present invention shall be subject to the claims. Those skilled in the art should know that any modification, equivalent substitution and improvement based on the substantial spirit of the present invention shall be within the substantial protection scope of the present invention.
Claims
1. A logic computing ECL biosensor based on a programmable allosteric DNAzyme is prepared by the following method: (1) Pretreatment of electrodes; (2) Adding SnO2 / chitosan / g-C3N4 nanocomposite material dropwise onto the pretreated electrode surface; (3) Modifying the substrate hairpin probe on the electrode surface; (4) Add MCH to prevent nonspecific binding; (5) adding a cyclic amplification unit constructed by assembled different logic calculation gates, and incubating the cyclic amplification unit with the substrate hairpin probe to form a programmable allosteric DNAzyme structure; the different logic calculation gates include a YES gate, an OR gate, an AND gate, an INHIBIT gate and a 2:1 MUX gate; wherein, The cyclic amplification unit constructed by the YES gate is obtained by mixing 1.0 μM auxiliary A chain A-YES, 1.0 μM target miRNA and 1.0 μM auxiliary B chain B-YES / B2 locked by DNA brake B2; wherein B-YES / B2 is formed by annealing DNA brake B2 with auxiliary B chain B-YES; The OR gate constructed cyclic amplification unit is obtained by mixing 1.0 μM auxiliary A chain A-OR, 1.0 μM target miRNA, and 1.0 μM auxiliary B chain B-OR / B1 / B2 locked by DNA brakes B1 and B2; wherein B-OR / B1 / B2 is formed by annealing DNA brakes B1 and B2 together with auxiliary B chain B-OR; The cyclic amplification unit constructed by AND gate is obtained by mixing auxiliary A chain A-AND / B3 / B4 locked by 1.0μM DNA brakes B3 and B4, 1.0μM target miRNA, and 1.0μM auxiliary B chain B-AND; wherein A-AND / B3 / B4 is formed by annealing DNA brakes B3 and B4 together with auxiliary A chain A-AND; The cyclic amplification unit constructed by the INHIBIT gate is obtained by mixing the auxiliary A chain A-INH / B4 locked by 1.0μM brake B4, 1.0μM auxiliary B chain (B-INH), and 1.0μM target miRNA; wherein A-INH / B4 is formed by annealing the DNA brake B4 with the auxiliary A chain A-INH; The cyclic amplification unit constructed by 2:1MUX gate is obtained by mixing 1.0μM auxiliary B chain (B-MUX), 1.0μM auxiliary A chain locked by brake B5 (A-MUX / B5), 1.0μM auxiliary PB chain locked by brake B3, 1.0μM auxiliary PA chain and 1.0μM target miRNA; wherein, A-MUX / B5 is formed by annealing brake B5 with auxiliary A chain, and PB / B3 is formed by annealing brake B3 with auxiliary PB chain; (6) Add padlock probe, T4 DNA ligase, 10×T4 buffer, PEG4000, EXOⅢ and Mg 2+ Incubate at 37°C; (7) Combine dNTPs, Pi29 polymerase, Pi29 buffer and Mg 2+ , triggering the strand to form an RCA product with consecutive repeat copies; (8) Add the CdTe-RuSi NP-CONH-DNA probe to the electrode surface and incubate in a dark environment.
2. The ECL biosensor according to claim 1, characterized in that: Step (3) modification on the electrode surface refers to connecting the substrate hairpin probe to the electrode surface via a chemical bond; the substrate hairpin probe includes Si-HP(rA) and / or Si-HP1(rA), and their sequences are SEQ ID NO. 1 and SEQ ID NO. 2 in the sequence listing, respectively.
3. The ECL biosensor according to claim 1, characterized in that: In step (5), the sequences of auxiliary A chain A-YES, auxiliary A chain A-OR, auxiliary A chain A-AND, auxiliary A chain A-INH, auxiliary A chain A-MUX, auxiliary A chain PA, auxiliary B chain B-YES, auxiliary B chain B-OR, auxiliary B chain B-AND, auxiliary B chain B-INH, auxiliary B chain B-MUX, auxiliary B chain PB, target miRNA-499, target miRNA-328, target miRNA-15a, target miRNA-1233, brake B1, brake B2, brake B3, brake B4, and brake B5 required for different logical calculations are SEQ ID NO.3 to SEQ ID NO.23 in the sequence listing, respectively.
4. The ECL biosensor according to claim 1, characterized in that: Step (6) incubating at 37°C for 28-32 minutes to cyclize and produce circular DNA; the padlock probe sequence is SEQ ID NO.
24.
5. The ECL biosensor according to claim 1, characterized in that: Step (7) Add dNTPs, Pi29 polymerase and Mg 2+ Incubate at 37°C in the dark for 2 h to allow rolling circle amplification to occur, generating RCA products with continuous repeat copies.
6. The ECL biosensor according to claim 1, characterized in that: Prepared by the following method: (1) Polish the electrode with alumina slurry, rinse thoroughly with ultrapure water, ultrasonically treat in ethanol and water, and dry at room temperature; (2) Add 10 μL SnO2 / chitosan / g-C3N4 solution to the electrode surface; (3) Add 10 μL of 3 μM substrate hairpin probe with rA site to the electrode and incubate for 4 h to 6 h; (4) Add 1 mM MCH and incubate for half an hour; (5) adding different auxiliary chains, target miRNAs and brakes to assemble a series of different cyclic amplification units, which are co-incubated with substrate hairpin probes to form a complete allosteric DNAzyme; (6) 1 μM, 1 μL padlock probe, 0.05 U / μL, 1 μL T4 DNA ligase, 10× T4 buffer, PEG4000, EXOⅢ and 10 mM 10 μL Mg 2+ The two were dropped together on the electrode surface and incubated at 37°C for 30 min to directly cyclize and produce circular DNA; (7) Add 0.2 U / μL of 1 μL dNTP, 0.5 U / μL of 1 μL Pi29 polymerase, Pi29 buffer and 10 mM Mg 2+ , the circular DNA continues to expand along the trigger chain and finally generates an RCA product with continuous repeated copies. (8) 1 μM, 10 μL of CdTe-RuSi NP-CONH-DNA probe is added to the electrode surface and incubated in a dark environment for 3-4 hours; the sequence of the CdTe-RuSi NP-CONH-DNA probe is SEQ ID NO.
25.
7. Use of the ECL biosensor according to any one of claims 1 to 6 in preparing a detection system for detecting miRNA associated with acute myocardial infarction, wherein the miRNA associated with acute myocardial infarction is miRNA-499 and / or miRNA-328.
8. Use of the ECL biosensor according to any one of claims 1 to 6 in preparing a detection system for detecting miRNA associated with acute aortic dissection, wherein the miRNA associated with acute aortic dissection is miRNA-15a.
9. Use of the ECL biosensor according to any one of claims 1 to 6 in preparing a detection system for detecting miRNA associated with acute pulmonary embolism, wherein the miRNA associated with acute pulmonary embolism is miRNA-1233.
10. Use of the ECL biosensor according to any one of claims 1 to 6 in preparing a detection system for simultaneously identifying and detecting acute myocardial infarction, acute aortic dissection and acute pulmonary embolism.
